CORRECTION: Recent Comments On Myriad Genetics Comes From SeekingAlpha Post From The Capitolist 'Myriad: FOIAs Reveal 50% Downside As Majority Of EBITDA Potentially At Risk From Reduced Reimbursement Rates'